Francois Roubille: New ESC Consensus on Inflammation in Coronary Syndromes
Francois Roubille, Head of the Intensive Care Unit at University Hospital of Montpellier, shared a post on LinkedIn:
”New ESC consensus on inflammation in coronary syndromes!
Proud to share our new clinical consensus statement on inflammation in coronary syndromes, published in European Heart Journal: Acute Cardiovascular Care, on behalf of several ESC councils and working groups.
doi: 10.1093/ehjacc/zuag086
We review how inflammation drives the continuum from chronic coronary syndromes to acute coronary syndromes, integrating mechanisms, biomarkers, imaging, and clinical implications.
Key messages include:
- Inflammation is a modifiable but secondary driver of risk in coronary artery disease.
- High-sensitivity CRP is the most practical biomarker for routine clinical use.
- Inflammation assessment should never delay guideline-directed revascularization and prevention.
- Standard therapies and lifestyle changes already exert meaningful anti-inflammatory effects.
- Low-dose colchicine is currently the only widely implementable anti-inflammatory drug in everyday practice, in carefully selected patients.
Beyond summarizing the evidence, the document provides pragmatic guidance on when, how, and in whom to assess and treat inflammation in real-world clinical practice, emphasizing a holistic, patient-centred approach rather than an ‘inflammation-only’ strategy.
I hope this consensus will help colleagues integrate inflammation into coronary care in a balanced way – bridging mechanistic insights, trial data, and daily decision-making.”
Stay updated with Hemostasis Today.
-
Aug 16, 2026, 14:52Connie Montgomery: Enjoyed My Opportunity to Facilitate and Speak at BDC 2026
-
Aug 16, 2026, 14:47Targeted Outside-In Signaling Inhibition – Dissociating Thrombosis from Hemostasis – JTH
-
Aug 16, 2026, 14:38Christopher Hanson: Broad-Spectrum Platelet Inhibition via Non-Odorant OR2L13 Agonists
-
Aug 16, 2026, 14:27Preeti Verma: The Case of the Missing Clue – Why Databases Need a Clinician’s Eye
-
Aug 16, 2026, 14:22FDA Licenses First Freeze-Dried Plasma Product in the United States
-
Aug 16, 2026, 14:20Christopher Cannon: Discontinuation vs. Continuation of Statin Therapy in Adults Aged Under 75
-
Aug 16, 2026, 13:53Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community
-
Aug 16, 2026, 13:46Sagar Bejalwar: A Rare Bleeding Disorder and the Importance of Specialized Care
-
Aug 16, 2026, 13:39Sharun Khan: Advancing Regenerative Medicine Through Veterinary Translational Science